These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 21329788

  • 21. New serotonin 5-HT(6) ligands from common feature pharmacophore hypotheses.
    Kim HJ, Doddareddy MR, Choo H, Cho YS, No KT, Park WK, Pae AN.
    J Chem Inf Model; 2008 Jan; 48(1):197-206. PubMed ID: 18044950
    [Abstract] [Full Text] [Related]

  • 22. Discovery of 5-HT6 receptor ligands based on virtual HTS.
    Tasler S, Kraus J, Wuzik A, Müller O, Aschenbrenner A, Cubero E, Pascual R, Quintana-Ruiz JR, Dordal A, Mercè R, Codony X.
    Bioorg Med Chem Lett; 2007 Nov 15; 17(22):6224-9. PubMed ID: 17892934
    [Abstract] [Full Text] [Related]

  • 23. 5-HT6 receptors: a novel target for cognitive enhancement.
    Mitchell ES, Neumaier JF.
    Pharmacol Ther; 2005 Dec 15; 108(3):320-33. PubMed ID: 16005519
    [Abstract] [Full Text] [Related]

  • 24. Indene-based scaffolds. Design and synthesis of novel serotonin 5-HT6 receptor ligands.
    Alcalde E, Mesquida N, Frigola J, López-Pérez S, Mercè R.
    Org Biomol Chem; 2008 Oct 21; 6(20):3795-810. PubMed ID: 18843410
    [Abstract] [Full Text] [Related]

  • 25. Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligands.
    Liu KG, Lo JR, Comery TA, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Robichaud AJ.
    Bioorg Med Chem Lett; 2009 Jun 15; 19(12):3214-6. PubMed ID: 19433358
    [Abstract] [Full Text] [Related]

  • 26. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
    Li Z, Huang M, Prus AJ, Dai J, Meltzer HY.
    Brain Res; 2007 Feb 23; 1134(1):70-8. PubMed ID: 17207474
    [Abstract] [Full Text] [Related]

  • 27. 5-HT6 receptor memory and amnesia: behavioral pharmacology--learning and memory processes.
    Meneses A, Pérez-García G, Ponce-Lopez T, Castillo C.
    Int Rev Neurobiol; 2011 Feb 23; 96():27-47. PubMed ID: 21329783
    [Abstract] [Full Text] [Related]

  • 28. [Recent advances in neuropharmacology of the centrally acting antitussive drugs].
    Kamei J.
    Yakubutsu Seishin Kodo; 1993 Oct 23; 13(5):271-84. PubMed ID: 8266738
    [Abstract] [Full Text] [Related]

  • 29. Highly potent, non-basic 5-HT6 ligands. Site mutagenesis evidence for a second binding mode at 5-HT6 for antagonism.
    Harris RN, Stabler RS, Repke DB, Kress JM, Walker KA, Martin RS, Brothers JM, Ilnicka M, Lee SW, Mirzadegan T.
    Bioorg Med Chem Lett; 2010 Jun 01; 20(11):3436-40. PubMed ID: 20434910
    [Abstract] [Full Text] [Related]

  • 30. Novel 7-phenylsulfanyl-1,2,3,4,10,10a-hexahydro-pyrazino[1,2-a]indoles as dual serotonin 5-HT2C and 5-HT6 receptor ligands.
    Krogsgaard-Larsen N, Jensen AA, Kehler J.
    Bioorg Med Chem Lett; 2010 Sep 15; 20(18):5431-3. PubMed ID: 20719507
    [Abstract] [Full Text] [Related]

  • 31. Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists.
    Ivachtchenko AV, Golovina ES, Kadieva MG, Koryakova AG, Kovalenko SM, Mitkin OD, Okun IM, Ravnyeyko IM, Tkachenko SE, Zaremba OV.
    Bioorg Med Chem; 2010 Jul 15; 18(14):5282-90. PubMed ID: 20541425
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Advances in the design of 5-HT6 receptor ligands with therapeutic potential.
    Witty D, Ahmed M, Chuang TT.
    Prog Med Chem; 2009 Jul 15; 48():163-224. PubMed ID: 21544960
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Peripheral serotoninergic receptor sensitivity in senile dementia of the Alzheimer type.
    Thomas DR, Jones E, Warner N, Harris B, Williams P, Bentley P.
    Biol Psychiatry; 1988 Jan 15; 23(2):136-40. PubMed ID: 3334883
    [Abstract] [Full Text] [Related]

  • 38. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A.
    Rev Neurol (Paris); 1994 Jan 15; 150(1):3-15. PubMed ID: 7801037
    [Abstract] [Full Text] [Related]

  • 39. Effect of serotonin 1A agonist tandospirone on depression symptoms in senile patients with dementia.
    Masuda Y, Akagawa Y, Hishikawa Y.
    Hum Psychopharmacol; 2002 Jun 15; 17(4):191-3. PubMed ID: 12404687
    [Abstract] [Full Text] [Related]

  • 40. [Serotonin receptors (results of the pharmacological study)].
    Valeeva LA, Sergeev PV, Shimanovskiĭ NL.
    Eksp Klin Farmakol; 1997 Jun 15; 60(6):57-61. PubMed ID: 9460603
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.